Seeking Alpha

Navidea Biopharmaceuticals (NAVB +3.2%) moves up today after pricing its 1.54M shares secondary...

Navidea Biopharmaceuticals (NAVB +3.2%) moves up today after pricing its 1.54M shares secondary offering at $3.10 per share, just a penny shy of yesterday's close. The gross proceeds of sale total approximately $4.8M, and the company plans to use the proceeds to fund it's ongoing operations.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|